Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Patients whose metastatic colorectal cancer has progressed following chemotherapy and who lack mutations in the RAS and BRAF ...

Data presented at the ASCO Gastrointestinal Cancers Symposium showed the regimen may be a new option, but it comes with more treatment and financial toxicity.

The addition of trastuzumab and pertuzumab to chemotherapy was associated with increased toxicity in patients with ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.